Christof Vulsteke unpaid guest prof.

Publications Christof Vulsteke

Tolerability of the niraparib individualized starting dose in the PRIMA/ ENGOT-OV26/GOG-3012 trial of niraparib first-line maintenance therapy

Source
European journal of cancer - ISSN 0959-8049-208 (2024) p. 1-9
Author(s)
    Christof Vulsteke, Setsuko K. Chambers, Maria Jesus Rubio Perez, John K. Chan, Nicoline Raaschou-Jensen, Ying Zhuo, Domenica Lorusso, Thomas J. Herzog, Thibault Motte de la Rouge, Jessica A. Thomes Pepin, Elena Ioana Braicu, Lee-may Chen, Tally Levy, James F. Barter, M. Pilar Barretina-Ginesta, Eric Joosens, Whitney York, Izabela A. Malinowska, Antonio Gonzalez-Martin, Bradley J. Monk

Sexual satisfaction and its predictors in patients with advanced cancer and their family caregivers in six European countries : baseline data from the DIAdIC study

Source
Psycho-oncology : journal of the psychological, social and behavioral dimensions of cancer - ISSN 1057-9249-33:6 (2024) p. 1-11
Author(s)
    Orphe Matthys, Sigrid Dierickx, Vincent Van Goethem, Luc Deliens, Lore Lapeire, Aglaja De Pauw, Peter Hudson, Christof Vulsteke, Karen Geboes, Stefanie De Waele, Isabelle Spoormans, Silvia Di Leo, Monica Guberti, Ulrik Sorensen Schmidt, David Scott, Richard Harding, Erica Witkamp, Michael Connolly, Aline de Vleminck, Joachim Cohen

Health-related quality of life in patients with previously treated advanced urothelial carcinoma from EV-301 : a phase 3 trial of enfortumab vedotin versus chemotherapy

Source
European urology - ISSN 0302-2838-85:6 (2024) p. 574-585
Author(s)
    Jonathan E. Rosenberg, Ronac Mamtani, Guru P. Sonpavde, Yohann Loriot, Ignacio Duran, Jae-Lyun Lee, Nobuaki Matsubara, Christof Vulsteke, Daniel Castellano, Srikala S. Sridhar, Helle Pappot, Howard Gurney, Jens Bedke, Michiel S. van der Heijden, Luca Galli, Bhumsuk Keam, Naoya Masumori, Johannes Meran, Peter H. O'Donnell, Se Hoon Park, Enrique Grande, Lisa Sengelov, Hiroji Uemura, Konstantina Skaltsa, Mary Campbell, Maria Matsangou, Chunzhang Wu, Zsolt Hepp, Caroline Mckay, Thomas Powles, Daniel P. Petrylak

Enfortumab vedotin and pembrolizumab in untreated advanced urothelial cancer

Source
The New England journal of medicine - ISSN 0028-4793-390:10 (2024) p. 875-888
Author(s)
    T. Powles, B.P. Valderrama, S. Gupta, J. Bedke, E. Kikuchi, J. Hoffman-Censits, G. Iyer, Christof Vulsteke, S.H. Park, S.J. Shin, D. Castellano, G. Fornarini, J.R. Li, M. Guemues, N. Mar, Y. Loriot, A. Flechon, I. Duran, A. Drakaki, S. Narayanan, X. Yu, S. Gorla, B. Homet Moreno, M.S. van der Heijden